Nitroglycerin lactose is a pharmaceutical preparation where nitroglycerin—a potent vasodilator—is combined with lactose as an inert carrier or diluent, typically in tablet or capsule form. It is used mainly for the prevention and treatment of angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart. Nitroglycerin works by relaxing and widening blood vessels, which improves oxygen delivery to the heart muscle and reduces cardiac workload. The inclusion of lactose helps stabilize the nitroglycerin and allows for accurate dosing, especially in sublingual or extended-release formulations. It is grouped under the following drug class(es): Nitrates and Vasodilating agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dmbsfypshncyar-Rimjuyidsa-N. Its PubChem CID is 131712755.
Nitroglycerin lactose
| Molecular Formula | C15H27N3O20 |
|---|---|
| Molecular Weight | 569.38 g/mol |
| Synonyms | 1,3-dinitrooxypropan-2-yl nitrate;(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nitroglycerin lactose is a pharmaceutical preparation where nitroglycerin—a potent vasodilator—is combined with lactose as an inert carrier or diluent, typically in tablet or capsule form.
The listed molecular formula is C15H27N3O20.
The listed molecular weight is 569.38 g/mol.
1,3-dinitrooxypropan-2-yl nitrate;(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol.
The source lists Dmbsfypshncyar-Rimjuyidsa-N.
It is listed under Nitrates and Vasodilating agents.